Business Context and Reporting Period
This Form 8-K was filed by Trovagene, Inc. (not Cardiff Oncology, Inc.) on March 10, 2016. The report announces the issuance of a press release detailing financial results for the three months and the full year ended December 31, 2015.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not disclose specific material changes versus prior periods. It serves solely as a notification that financial results for the period ended December 31, 2015, have been released.
Guidance, Outlook, and Risks
The text contains no management commentary, guidance, outlook, or discussion of risks and contingencies. The information disclosed under Item 2.02 is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the correct registrant name is Trovagene, Inc., not Cardiff Oncology, Inc.
- Review Exhibit 99.1 (Press Release dated March 10, 2016) for actual financial figures.
- Confirm the reporting period covers the three months and year ended December 31, 2015.